Romios Gold Resources (RG) Stock Price, News & Analysis

Company Overview

Romios Gold Resources Inc. engages in the exploration of precious and base metals in Canada. The company explores for gold, silver, and copper deposits. It holds interest in the Golden Triangle Area project covering an area of 45,105 hectares located in British Columbia; and 20% interest in the Thunder Bay silver district project comprising 87 claims covering an area of 1,853 hectares located in northwestern Ontario. The company holds interest in 109 gold-silver-copper claims, and 22 Lode claims in located in Nevada. Romios Gold Resources Inc. was founded in 1995 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.01 to C$0.01
• 50-Day Range: C$0.01 to C$0.02
• 52-Week Range: C$0.01 to C$0.03
• Volume: 4,000 shs
• Average Volume: 170,977 shs
• Market Capitalization: C$2.76 million
• P/E Ratio: N/A
• Dividend Yield: 4.98%
• Price Target: N/A
• Consensus Rating: N/A

RG Stock Analysis - Frequently Asked Questions

How have RG shares performed this year?

Romios Gold Resources' stock was trading at C$0.02 at the start of the year. Since then, RG stock has decreased by 33.3% and is now trading at C$0.01.
View the best growth stocks for 2024 here.

How do I buy shares of Romios Gold Resources?

Shares of RG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Romios Gold Resources own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Romios Gold Resources investors own include MiMedx Group (MDXG), Northern Dynasty Minerals (NAK), ProQR Therapeutics (PRQR), Vistagen Therapeutics (VTGN), Aben Resources (ABN), Blue Apron (APRN) and Aqua Metals (AQMS).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Gold
• Sub-Industry: N/A
• Current Symbol: CVE:RG
• CUSIP: N/A
• CIK: N/A
• Web: www.romios.com
• Phone: +1-416-2214124
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-1,230,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -425.88%
• Return on Assets: -34.67%

Debt

• Debt-to-Equity Ratio: 75.09
• Current Ratio: 0.14
• Quick Ratio: 1.32

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 275,620,000
• Free Float: N/A
• Market Cap: C$2.76 million
• Optionable: Not Optionable
• Beta: 1.61